Inhibikase Therapeutics, Inc.

Q4 2023 13F Holders

Symbol
IKT
CUSIP
45719W205
Type
Equity
Class
COM NEW
Num filings
13
Total reported value, excl. options
$301 k
Manager Report Date Value ($000) Shares Option Type